Senior Appointments Further Strengthen Pharmaceutical Profiles Scientific Expertise

Dr Andrew Rankin joins Pharmaceutical Profiles (Nottingham, UK) as Chief Scientific Officer. He brings considerable R&D experience, spanning both academic and pharmaceutical environments, having spent 14 years in leadership roles with Pfizer, from pre-clinical and exploratory drug development through to successful global regulatory approvals. Andrew will direct and develop the company’s scientific innovation.

Back to news